SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-056967
Filing Date
2019-10-28
Accepted
2019-10-28 17:15:37
Documents
12
Period of Report
2019-10-25
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921264d1_8k.htm   iXBRL 8-K 26195
  Complete submission text file 0001104659-19-056967.txt   200513

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA icpt-20191025.xsd EX-101.SCH 3207
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20191025_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20191025_pre.xml EX-101.PRE 22724
12 EXTRACTED XBRL INSTANCE DOCUMENT tm1921264d1_8k_htm.xml XML 3615
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 191173826
SIC: 2834 Pharmaceutical Preparations